Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Schiff

Showing results (171-180 of 305) with videos related to

Pageof 31
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2007
Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphomaGaurav D Shah, Joachim Yahalom, Denise D Correa, et al.
Cancer Research|March 15, 2008
PTEN has tumor-promoting properties in the setting of gain-of-function p53 mutationsYunqing Li, Fadila Guessous, Sherwin Kwon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2008
The use of magnetic resonance imaging to noninvasively detect genetic signatures in oligodendrogliomaRobert Brown, Magdalena Zlatescu, Angelique Sijben, et al.
Journal of Neuro-Oncology|March 4, 2021
Fluid attenuation in non-contrast-enhancing tumor (nCET): an MRI Marker for Isocitrate Dehydrogenase (IDH) mutation in GlioblastomaSohil H Patel, Prem P Batchala, Thomas J Eluvathingal Muttikkal, et al.
Journal of Neuro-Oncology|January 21, 2026
Magnetic resonance imaging features differentiate histologic and molecular subtypes of glioblastoma IDH-Wild type CNS WHO grade 4Sohil H Patel, Shanna Mayorov, Wooil Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2011
Primary central nervous system lymphomas: a validation study of array-based comparative genomic hybridization in formalin-fixed paraffin-embedded tumor specimensEsteban Braggio, Ellen Remstein McPhail, William Macon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2024
Multidisciplinary Management of Isocitrate Dehydrogenase-Mutated Gliomas in a Contemporary Molecularly Defined EraRupesh Kotecha, David Schiff, Arnab Chakravarti, et al.
Neuro-Oncology Practice|December 29, 2025
Presenting clinical and radiographic features of diffuse glioma molecular subtypes in accordance with the 2021 CNS5 WHO classificationJasmin Jo, Mark Willy L Mondia, Josephine Arewa, et al.
Biomedical Physics & Engineering Express|August 2, 2024
An end-to-end deep learning pipeline to derive blood input with partial volume corrections for automated parametric brain PET mappingRugved Chavan, Gabriel Hyman, Zoraiz Qureshi, et al.
Journal of Neuro-Oncology|September 10, 2020
Automated apparent diffusion coefficient analysis for genotype prediction in lower grade glioma: association with the T2-FLAIR mismatch signEric Aliotta, Sunil W Dutta, Xue Feng, et al.
Pageof 31

Showing results (171-180 of 305) with videos related to

Sort By:
Pageof 31
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2007
Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphomaGaurav D Shah, Joachim Yahalom, Denise D Correa, et al.
Cancer Research|March 15, 2008
PTEN has tumor-promoting properties in the setting of gain-of-function p53 mutationsYunqing Li, Fadila Guessous, Sherwin Kwon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2008
The use of magnetic resonance imaging to noninvasively detect genetic signatures in oligodendrogliomaRobert Brown, Magdalena Zlatescu, Angelique Sijben, et al.
Journal of Neuro-Oncology|March 4, 2021
Fluid attenuation in non-contrast-enhancing tumor (nCET): an MRI Marker for Isocitrate Dehydrogenase (IDH) mutation in GlioblastomaSohil H Patel, Prem P Batchala, Thomas J Eluvathingal Muttikkal, et al.
Journal of Neuro-Oncology|January 21, 2026
Magnetic resonance imaging features differentiate histologic and molecular subtypes of glioblastoma IDH-Wild type CNS WHO grade 4Sohil H Patel, Shanna Mayorov, Wooil Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2011
Primary central nervous system lymphomas: a validation study of array-based comparative genomic hybridization in formalin-fixed paraffin-embedded tumor specimensEsteban Braggio, Ellen Remstein McPhail, William Macon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2024
Multidisciplinary Management of Isocitrate Dehydrogenase-Mutated Gliomas in a Contemporary Molecularly Defined EraRupesh Kotecha, David Schiff, Arnab Chakravarti, et al.
Neuro-Oncology Practice|December 29, 2025
Presenting clinical and radiographic features of diffuse glioma molecular subtypes in accordance with the 2021 CNS5 WHO classificationJasmin Jo, Mark Willy L Mondia, Josephine Arewa, et al.
Biomedical Physics & Engineering Express|August 2, 2024
An end-to-end deep learning pipeline to derive blood input with partial volume corrections for automated parametric brain PET mappingRugved Chavan, Gabriel Hyman, Zoraiz Qureshi, et al.
Journal of Neuro-Oncology|September 10, 2020
Automated apparent diffusion coefficient analysis for genotype prediction in lower grade glioma: association with the T2-FLAIR mismatch signEric Aliotta, Sunil W Dutta, Xue Feng, et al.
Pageof 31